Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Jounce Therapeutics Inc (JNCE)  
$1.88 0.00 (0.00%) as of 4:30 Wed 5/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 51,230,000
Market Cap: 96.31(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.88 - $1.88
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Jounce Therapeutics is a clinical-stage immunotherapy company focuses on the treatment of cancer by developing therapies that enable the immune system to attack tumors. Co.'s product candidates include: JTX-8064, an antibody that binds to Leukocyte Immunoglobulin Like Receptor B2; Vopratelimab, a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells commonly found in several solid tumors; Pimivalimab, a clinical-stage anti-PD-1 antibody for potential use in combination with its product candidates; and GS-1811, a monoclonal antibody that depletes T regulatory cells in the tumor microenvironment.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 85,987
Total Buy Value $0 $0 $0 $85,958
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 124,313
Total Sell Value $0 $0 $0 $167,105
Total People Sold 0 0 0 4
Total Sell Transactions 0 0 0 9
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 158
  Page 2 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Drapkin Kimberlee C CFO and Treasurer   •       –      –    2022-02-01 4 A $0.00 $0 D/D 27,500 80,114     -
   Trehu Elizabeth Chief Medical Officer   •       –      –    2022-01-10 4 S $6.65 $35,764 D/D (5,378) 85,202 33%     
   Murray Richard /ca/ CEO and President   •       •      –    2022-01-10 4 S $6.65 $159,095 D/D (23,924) 185,577 33%     
   Cole Hugh M Chief Business Officer   •       –      –    2022-01-10 4 S $6.65 $41,263 D/D (6,205) 64,216 33%     
   Drapkin Kimberlee C CFO and Treasurer   •       –      –    2022-01-10 4 S $6.65 $54,676 D/D (8,222) 52,614 33%     
   Trehu Elizabeth Chief Medical Officer   •       –      –    2022-01-07 4 S $7.30 $21,937 D/D (3,005) 90,580 34%     
   Murray Richard /ca/ CEO and President   •       •      –    2022-01-07 4 S $7.30 $97,601 D/D (13,370) 209,501 34%     
   Cole Hugh M Chief Business Officer   •       –      –    2022-01-07 4 S $7.30 $25,316 D/D (3,468) 70,421 34%     
   Drapkin Kimberlee C CFO and Treasurer   •       –      –    2022-01-07 4 S $7.30 $33,544 D/D (4,595) 60,836 34%     
   Pfeffer Cary Director   –       •      –    2021-11-12 4 S $0.00 $0 I/I (0) 0 22%     
   Pfeffer Cary Director   –       •      –    2021-09-15 4 AS $0.00 $0 I/I (0) 0 -10%     
   Levin Mark J 10% Owner   –       –       •   2021-09-15 4 AS $0.00 $0 D/D (1,750,000) 2,697,829 -10%     
   Levin Mark J 10% Owner   –       –       •   2021-06-10 4 AS $0.00 $0 D/D (1,500,000) 4,447,829 21%     
   Pfeffer Cary Director   –       •      –    2021-06-10 4 AS $0.00 $0 I/I (0) 0 21%     
   Levin Mark J 10% Owner   –       –       •   2021-05-25 4 S $8.00 $4,420,160 D/D (552,520) 5,947,829 4%     
   Higgons John Duncan Director   –       •      –    2021-04-15 4 AS $10.00 $2,000 D/D (200) 9,713 -38%     
   Trehu Elizabeth Chief Medical Officer   •       –      –    2021-03-31 4 AS $10.09 $83,747 D/D (8,300) 93,585 -49%     
   Trehu Elizabeth Chief Medical Officer   •       –      –    2021-03-31 4 OE $4.02 $33,366 D/D 8,300 101,885     -
   Trehu Elizabeth Chief Medical Officer   •       –      –    2021-03-30 4 AS $10.00 $1,000 D/D (100) 93,585 -46%     
   Trehu Elizabeth Chief Medical Officer   •       –      –    2021-03-30 4 OE $4.02 $402 D/D 100 93,685     -
   Trehu Elizabeth Chief Medical Officer   •       –      –    2021-03-29 4 AS $10.09 $51,459 D/D (5,100) 93,585 -47%     
   Trehu Elizabeth Chief Medical Officer   •       –      –    2021-03-29 4 OE $4.02 $20,502 D/D 5,100 98,685     -
   Higgons John Duncan Director   –       •      –    2021-03-15 4 AS $12.80 $2,560 D/D (200) 9,913 -55%     
   Pfeffer Cary Director   –       •      –    2021-03-11 4 AS $0.00 $0 I/I (0) 0 -59%     
   Levin Mark J 10% Owner   –       –       •   2021-03-11 4 AS $0.00 $0 D/D (1,250,000) 6,500,349 -59%     
  158 Records found
  1  2  3  4  5  6  7   
  Page 2 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us